Higher genetically predicted low-density lipoprotein levels increase the renal cancer risk independent of triglycerides and high-density lipoprotein levels: a Mendelian randomization study.
机构:[1]Department of Urology, Institute of Urology (Laboratory of Reconstructive Urology), West China Hospital, Sichuan University, Chengdu, Sichuan, China四川大学华西医院
The causation between lipids and renal cancer remains inconclusive. Our purpose is to explore the causal relationships between the three primary lipid metabolism-related substances, namely triglycerides (TG), low-density lipoprotein (LDL), and high-density lipoprotein (HDL) with the risk of renal cancer using Mendelian randomization (MR) methods. Genetic instruments for lipids were acquired from the UK Biobank. Outcome data were from the FinnGen study (1397 renal cancer cases and 204,070). Single-variable MR (SVMR) and multi-variable MR (MVMR) analyses were conducted with TwoSampleMR package based on R 4.0.3. The random-effect inverse-variance weighted (IVW), MR-Egger, weighted-median method, and weighted mode were four main computing methods. We found that per 1 SD elevated LDL level was is causally associated with renal cancer occurrence based on SVMR (OR, 1.31, 95% CI: 1.05-1.64, P=0.016). Similar significant associations were found in other methods. But the results of SVMR didn't support significant associations between TG, and HDL with renal cancer risk in all methods. The association between LDL and renal cancer was still significant in MVMR analysis (OR for IVW method: 1.22 per 1-standard-deviation-higher trait, 95% CI: 1.11-1.34, P<0.001; OR for MR-Egger: 1.22 per 1-standard-deviation-higher trait, 95% CI: 1.01-1.47, P=0.042) when taking TG and HDL into consideration. Our study supported that elevated serum LDL levels is causally associated with an increased risk of renal cancer independent of TG and HDL. This article is protected by copyright. All rights reserved.This article is protected by copyright. All rights reserved.
基金:
China Postdoctoral Science Foundation, Grant/
Award Number: 2019M653415; West China
Hospital, Sichuan University, Grant/Award
Number: 2019HXBH087
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|1 区医学
小类|2 区肿瘤学
最新[2023]版:
大类|2 区医学
小类|2 区肿瘤学
第一作者:
第一作者机构:[1]Department of Urology, Institute of Urology (Laboratory of Reconstructive Urology), West China Hospital, Sichuan University, Chengdu, Sichuan, China
通讯作者:
通讯机构:[1]Department of Urology, Institute of Urology (Laboratory of Reconstructive Urology), West China Hospital, Sichuan University, Chengdu, Sichuan, China[*1]Department of Urology, West China Hospital, Sichuan University, No.37 Guoxue Alley, Wuhou District, Chengdu City, Sichuan Province, China
推荐引用方式(GB/T 7714):
Ma Yucheng,Jian Zhongyu,Xiang Liyuan,et al.Higher genetically predicted low-density lipoprotein levels increase the renal cancer risk independent of triglycerides and high-density lipoprotein levels: a Mendelian randomization study.[J].International journal of cancer.2022,doi:10.1002/ijc.34032.
APA:
Ma Yucheng,Jian Zhongyu,Xiang Liyuan&Jin Xi.(2022).Higher genetically predicted low-density lipoprotein levels increase the renal cancer risk independent of triglycerides and high-density lipoprotein levels: a Mendelian randomization study..International journal of cancer,,
MLA:
Ma Yucheng,et al."Higher genetically predicted low-density lipoprotein levels increase the renal cancer risk independent of triglycerides and high-density lipoprotein levels: a Mendelian randomization study.".International journal of cancer .(2022)